Vimarsana
Biggest News Aggregation in the World

Page 40 - Simon Vincent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simon Vincent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simon Vincent Today - Breaking & Trending Today

Breast cancer 'most common cancer in the world' | Wharfedale Observer - Vimarsana News

Breast cancer 'most common cancer in the world' | Wharfedale Observer

Lung cancer was previously the most prevalent cancer. But new research from the International Agency for Research on Cancer (IARC) suggests that breast cancer in women is now more common, with 2.3 million cases diagnosed in 2020. Breast cancer now accounts for 11.7% of all new cancer cases, the IARC said. Lung cancer accounted for 11.4% of new cancers in 2020. Make sure you're aware of the signs and symptoms of breast cancer and that you check your breasts regularly. Speak to your #GP if you notice any changes. https://t.co/PT1od0DnZ9#BreastCancerAwarenessMonthpic.twitter.com/HmrhvaFfci Bowel...

Existing drug could treat 'aggressive' triple-negative breast cancer – study | Burnham and Highbridge Weekly News - Vimarsana News

Existing drug could treat 'aggressive' triple-negative breast cancer – study | Burnham and Highbridge Weekly News

An already approved cancer drug could be used to treat more aggressive forms of breast cancer, new research has found. Researchers funded by Breast Cancer Now have identified a specific defect in some triple-negative breast cancers and a pre-existing drug that could help treat the disease. The new research, led by Dr Rachael Natrajan at The Institute of Cancer Research, discovered a way to identify triple-negative breast tumours that could be more likely to respond to a class of drugs called CDK4/6 inhibitors, including palbociclib. Palbociclib is currently used to treat other breast cancers ...

Medical breakthrough could help thousands in UK living with an aggressive type of breast cancer - Vimarsana News

Medical breakthrough could help thousands in UK living with an aggressive type of breast cancer

Medical breakthrough could help thousands in UK living with an aggressive type of breast cancer Maya Oppenheim © Provided by The Independent Thousands of women living in the UK suffering from an aggressive type of breast cancer could be helped by a newly identified drug, according to a study. The research, carried out by The Institute of Cancer Research, found medicine presently used to help other breast cancers that have spread to another area of the body, could actually be utilised to help around a fifth of women who have triple negative breast cancer. Around 55,000 women ...

Source: msn.com
Aggressive breast cancers could be fought with drug already being used in treatment - Vimarsana News

Aggressive breast cancers could be fought with drug already being used in treatment

The medication is currently used on other breast tumours that have spread through the body. But the researchers found the potential to use it to treat around a fifth of people with triple-negative breast cancer. Dr Natrajan said the study “suggests the exciting possibility that an already-approved breast cancer drug could be used to help women with this type of disease”. Clinical trials will take several years but if they are successful, CDK4/6 inhibitors could be used within five years. Triple-negative breast cancer refers to tumours lacking three molecules normally used to classify it â...

The Best of Business Intelligence 2020 - Vimarsana News

The Best of Business Intelligence 2020

The Best of Business Intelligence 2020 by The Best of Business Intelligence 2020 The BOBI (Best Of Business Intelligence) awards give BI specialists the opportunity to showcase their skills and expertise. It’s a chance to celebrate the contribution they make to UK pharma, the NHS and patients. The awards ceremony was streamed on December 4, with hosts Wilf Iliffe, 14 Four Analytics (BOBI Chair) and Kelly West, Boehringer Ingelheim (BHBIA Board member) on stage, and each sponsor joining via video to announce winners. The awards are divided into three types: Task-based challenges The Analys...